ForGrowth NAP B.V.
Insider
CompanySelling only24 10b5-1 trades
- 2024
- Dec 30, 2024
- 8
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies ForGrowth NAP B.V. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael H. Davidson - $25.55M in NAMS purchases and sales in the last 12 months
- Louise Frederika Kooij - $16.75M in NAMS purchases and sales in the last 12 months
- Johannes Jacob Pieter Kastelein - $15.52M in NAMS purchases and sales in the last 12 months
- Mayur Ian Somaiya - $3.43M in NAMS purchases and sales in the last 12 months
- Louis G. Lange - $2.19M in NAMS purchases and sales in the last 12 months
- John W. Smither - $41K in NAMS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
What is ForGrowth NAP B.V.?
ForGrowth NAP B.V. is a corporate entity of NewAmsterdam Pharma Co N.V. (NAMS). InsiderAlpha holds 8 primary Form 4 filings for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did ForGrowth NAP B.V. last file a Form 4?
The most recent primary Form 4 on record is dated 30 December 2024, one of 8 filings going back to 2024.
Has ForGrowth NAP B.V. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 24 open-market sales ($29.26M) across all tracked filings.
